Cimicoxib (CX) 是一种口服有效的选择性COX-2(环加氧酶-2) 抑制剂。Cimicoxib 具有良好的抗炎和镇痛活性。Cimicoxib 的精确剂量 (2 mg/kg) 和近似剂量 (1.95-2.5 mg/kg) 对犬的药代动力学参数相似。
| 生物活性 | Cimicoxib (CX) is an orally active potent and selectiveCOX-2(cyclo-oxygenase-2) inhibitor. Cimicoxib exhibits promising anti-inflammatory and analgesic activity. The PK parameters of Cimicoxib in dogs given precise (2 mg/kg) and approximate doses (1.95-2.5 mg/kg) are similar[1]. |
| IC50& Target | |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
